http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104630338-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2013-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104630338-B |
| titleOfInvention | Application of RRM2B gene or protein thereof in liver cancer metastasis |
| abstract | The invention discloses an application of RRM2B gene or protein thereof in liver cancer metastasis. Specifically, the invention provides an application of ribonucleotide reductase subunit M2B (riboside-diphosphate reductase subunit M2B, RRM2B) gene or protein detection reagent thereof in preparing a kit for diagnosing liver cancer cell metastasis. In addition, the invention also provides the effect of RRM2B on inhibiting liver cancer metastasis. Provides a new way for diagnosing and treating liver cancer metastasis. |
| priorityDate | 2013-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 286.